{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:22:30Z","timestamp":1790882550563,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.rpth.2024.102623","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T17:42:35Z","timestamp":1731433355000},"page":"102623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Stability of the thromboxane B2 biomarker of low-dose aspirin pharmacodynamics in human whole blood and in long-term stored serum samples"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9280-3673","authenticated-orcid":false,"given":"Giovanna","family":"Petrucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Rizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Bellavia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Dentali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Frisullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Pitocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Ranalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Andrea","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Scala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Silingardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Zagarr\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gualberto","family":"Gussoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2024.102623_bib1","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/cvr\/cvab003","article-title":"The key contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosis","volume":"117","author":"Badimon","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.rpth.2024.102623_bib2","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.3389\/fphar.2019.01244","article-title":"Measurement of thromboxane biosynthesis in health and disease","volume":"10","author":"Patrono","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.rpth.2024.102623_bib3","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacc.2008.10.047","article-title":"Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin \u201cresistance.\u201d","volume":"53","author":"Santilli","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.rpth.2024.102623_bib4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0049-3848(80)90066-3","article-title":"Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects","volume":"17","author":"Patrono","year":"1980","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2024.102623_bib6","first-page":"4","article-title":"Comparing models for measuring ring strain of common cycloalkanes [abstract]","volume":"6","author":"Hobbs","year":"2004","journal-title":"Corinthian"},{"key":"10.1016\/j.rpth.2024.102623_bib8","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1160\/TH16-05-0349","article-title":"Patient-independent variables affecting the assessment of aspirin responsiveness by serum thromboxane measurement","volume":"116","author":"Petrucci","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102623_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41408-018-0078-3","article-title":"The aspirin regimens in essential thrombocythemia (ARES) phase II randomized trial design: implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting","volume":"8","author":"De Stefano","year":"2018","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.rpth.2024.102623_bib11","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/jth.14445","article-title":"Obesity is associated with impaired responsiveness to once-daily low-dose aspirin and in\u00a0vivo platelet activation","volume":"17","author":"Petrucci","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102623_bib12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2337\/db15-0936","article-title":"In\u00a0vivo platelet activation and aspirin responsiveness in type 1 diabetes","volume":"65","author":"Zaccardi","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.rpth.2024.102623_bib13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1182\/blood.2019004596","article-title":"A\u00a0randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia","volume":"136","author":"Rocca","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102623_bib14","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1111\/cts.13415","article-title":"Platelet thromboxane inhibition by low-dose aspirin in polycythemia vera: ex\u00a0vivo and in\u00a0vivo measurements and in silico simulation","volume":"15","author":"Petrucci","year":"2022","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.rpth.2024.102623_bib15","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1182\/blood-2011-06-359224","article-title":"Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target","volume":"119","author":"Pascale","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102623_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3232","article-title":"In\u00a0vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance","volume":"36","author":"Santilli","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.rpth.2024.102623_bib17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1751-553X.2012.01458.x","article-title":"The effect of selected pre-analytical phase variables on plasma thromboxane A2 measurements in humans","volume":"35","author":"Sadilkova","year":"2013","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.rpth.2024.102623_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/VHRM.S204925","article-title":"Stability of thromboxane in blood samples","volume":"15","author":"Helgad\u00f3ttir","year":"2019","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.rpth.2024.102623_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2018.01.010","article-title":"Influence of pre-analytical time and temperature conditions on serum thromboxane B2 levels","volume":"163","author":"van Diemen","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2024.102623_bib20","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1172\/JCI112341","article-title":"Estimated rate of thromboxane secretion into the circulation of normal humans","volume":"77","author":"Patrono","year":"1986","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.rpth.2024.102623_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12516","article-title":"Aspirin at 120: retiring, recombining, or repurposing?","volume":"5","author":"Patrono","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102623_bib22","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1161\/CIRCULATIONAHA.109.900589","article-title":"Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization","volume":"120","author":"Frelinger","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2024.102623_bib23","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1538-7836.2012.04723.x","article-title":"The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes","volume":"10","author":"Rocca","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102623_bib24","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/ajh.27418","article-title":"Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: the ARES trial","volume":"99","author":"Rocca","year":"2024","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2024.102623_bib25","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/cpt.694","article-title":"In silico modeling of the antiplatelet pharmacodynamics of low-dose aspirin in health and disease","volume":"102","author":"Giaretta","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.rpth.2024.102623_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268905","article-title":"Physiologically based modelling of the antiplatelet effect of aspirin: a tool to characterize drug responsiveness and inform precision dosing","volume":"17","author":"Giaretta","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2024.102623_bib27","article-title":"Precision antiplatelet therapy","volume":"7","author":"Rocca","year":"2023","journal-title":"Res Pract Thromb\u00a0Haemost"},{"key":"10.1016\/j.rpth.2024.102623_bib28","doi-asserted-by":"crossref","first-page":"385.e1","DOI":"10.1016\/j.ajog.2019.01.222","article-title":"Obesity and laboratory aspirin resistance in high-risk pregnant women treated with low-dose aspirin","volume":"220","author":"Finneran","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.rpth.2024.102623_bib29","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/00003246-199504000-00019","article-title":"Effects of temperature on bleeding time and clotting time in normal male and female volunteers","volume":"23","author":"Valeri","year":"1995","journal-title":"Crit Care Med"},{"key":"10.1016\/j.rpth.2024.102623_bib30","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1038\/srep03868","article-title":"Effects of storage time and temperature on coagulation tests and factors in fresh plasma","volume":"4","author":"Feng","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.rpth.2024.102623_bib31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/ije\/dyg023","article-title":"Stability of plasma analytes after delayed separation of whole blood: implications for epidemiological studies","volume":"32","author":"Clark","year":"2003","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.rpth.2024.102623_bib32","first-page":"146","article-title":"Red blood cell salvage analysis from clotted blood","volume":"17","author":"Craig","year":"2019","journal-title":"Blood Transfus"},{"key":"10.1016\/j.rpth.2024.102623_bib33","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1161\/CIRCULATIONAHA.111.085464","article-title":"Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the Antiplatelet Drug Resistances and Ischemic Events study","volume":"125","author":"Reny","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2024.102623_bib34","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/09537104.2015.1072147","article-title":"Aspirin response: differences in serum thromboxane B2 levels between clinical studies","volume":"27","author":"Brun","year":"2016","journal-title":"Platelets"},{"key":"10.1016\/j.rpth.2024.102623_bib35","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM199803123381101","article-title":"Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"338","author":"Caritis","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102623_bib36","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1111\/j.1538-7836.2010.04063.x","article-title":"Clinical predictors of dual aspirin and clopidogrel poor responsiveness in stable cardiovascular patients from the ADRIE study","volume":"8","author":"Fontana","year":"2010","journal-title":"J\u00a0Thromb Haemost"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037924003182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037924003182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:35:07Z","timestamp":1738802107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037924003182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2475037924003182"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2024.102623","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stability of the thromboxane B2 biomarker of low-dose aspirin pharmacodynamics in human whole blood and in long-term stored serum samples","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2024.102623","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"102623"}}